Literature DB >> 8269416

Optico-hypothalamic glioma: an analysis of 16 cases.

S Nishio1, I Takeshita, S Fujiwara, M Fukui.   

Abstract

We reviewed our experience of 16 patients with histologically proven optico-hypothalamic gliomas. They ranged in age from 0.3 to 15 years at the time of diagnosis. Fifteen tumors were located in the optic chiasm, optic nerve, optic tract and/or hypothalamus, while one tumor was confined to one optic nerve. All tumors were classified as low-grade astrocytomas, which were mainly composed of pilocytic astrocytes. No patient had associated neurofibromatosis. The initial treatment for tumors included surgery in 12, radiotherapy in 7, and chemotherapy in 4 patients. After treatment, visual function improved in 3 out of 14, and endocrine function improved in 1 out of 4 evaluable patients. The 5-year actuarial survival rate was 84.0%, and that at 10 years 71.1%. Our experience and the literature indicate that: (1) patients with disease limited to the optic nerve are adequately managed by resection alone; (2) chiasmal-hypothalamic gliomas behave variably, and progressive disease may occur late in the course of the illness; (3) gliomas that arise in patients under 2 years of age and involve the optic chiasm may act aggressively despite their histological benignity; (4) the beneficial effects of radiotherapy occur in about half of the patients; (5) although chemotherapy may be an effective adjuvant treatment modality, it is not an alternative to radiation therapy at present. Both surgery and irradiation therefore offer the best treatment now available for patients with progressive disease.

Entities:  

Mesh:

Year:  1993        PMID: 8269416     DOI: 10.1007/bf00302036

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  34 in total

1.  Radiotherapy in the management of primary gliomas involving the intracranial optic nerves and chiasm.

Authors:  D J Harter; J B Caderao; M E Leavens; S E Young
Journal:  Int J Radiat Oncol Biol Phys       Date:  1978 Jul-Aug       Impact factor: 7.038

2.  Piloid gliomas of the anterior optic pathways.

Authors:  R TYM
Journal:  Br J Surg       Date:  1961-11       Impact factor: 6.939

3.  Malignant evolution of childhood chiasmal pilocytic astrocytoma.

Authors:  W B Wilson; M Feinsod; W F Hoyt; S L Nielsen
Journal:  Neurology       Date:  1976-04       Impact factor: 9.910

4.  Optic nerve glioma: the role of radiation therapy.

Authors:  A B Montgomery; T Griffin; R G Parker; A J Gerdes
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

5.  Results of the treatment of children with recurrent gliomas with lomustine and vincristine.

Authors:  I B Lefkowitz; R J Packer; L N Sutton; K R Siegel; D A Bruce; A E Evans; L Schut
Journal:  Cancer       Date:  1988-03-01       Impact factor: 6.860

6.  Evaluation and management of gliomas of the anterior visual pathways.

Authors:  N R Miller; W J Iliff; W R Green
Journal:  Brain       Date:  1974-12       Impact factor: 13.501

7.  Optic glioma of childhood. Natural history and rationale for conservative management.

Authors:  W F Hoyt; S A Baghdassarian
Journal:  Br J Ophthalmol       Date:  1969-12       Impact factor: 4.638

8.  Aspects on the treatment of gliomas of the anterior visual pathway.

Authors:  H Bynke; E Kågström; K Tjernström
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-04

9.  Management of glioma of the optic nerve and/or chiasm: an analysis of 20 cases.

Authors:  D E Dosoretz; P H Blitzer; C C Wang; R M Linggood
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

10.  Evolution and outcome in malignant astroglial neoplasms of the cerebellum.

Authors:  G K Steinberg; L M Shuer; F K Conley; J W Hanbery
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

View more
  8 in total

1.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

Authors:  L Kornreich; S Blaser; M Schwarz; A Shuper; T H Vishne; I J Cohen; R Faingold; S Michovitz; B Koplewitz; G Horev
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

2.  Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Authors:  Michael J Fisher; Michael Loguidice; David H Gutmann; Robert Listernick; Rosalie E Ferner; Nicole J Ullrich; Roger J Packer; Uri Tabori; Robert O Hoffman; Simone L Ardern-Holmes; Trent R Hummel; Darren R Hargrave; Eric Bouffet; Joel Charrow; Larissa T Bilaniuk; Laura J Balcer; Grant T Liu
Journal:  Neuro Oncol       Date:  2012-04-03       Impact factor: 12.300

3.  Infarction following chiasmatic low grade glioma resection.

Authors:  Markus Hupp; Fabian Falkenstein; Brigitte Bison; Cora Mirow; Jürgen Krauss; Astrid Gnekow; Laszlo Solymosi; Monika Warmuth-Metz
Journal:  Childs Nerv Syst       Date:  2011-10-11       Impact factor: 1.475

4.  Diencephalic tumors in children: a 30-year experience of a single institution.

Authors:  Nalan Yazici; Ali Varan; Nejat Akalan; Figen Söylemezoğlu; Faruk Zorlu; Tezer Kutluk; Canan Akyüz; Münevver Büyükpamukçu
Journal:  Childs Nerv Syst       Date:  2011-02-25       Impact factor: 1.475

5.  Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children.

Authors:  T Kato; Y Sawamura; M Tada; J Ikeda; N Ishii; H Abe
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

Review 6.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 7.  Management of pilocytic astrocytoma with diffuse leptomeningeal spread: two cases and review of the literature.

Authors:  Henry E Aryan; Hal S Meltzer; Daniel C Lu; Burak M Ozgur; Michael L Levy; Derek A Bruce
Journal:  Childs Nerv Syst       Date:  2004-09-15       Impact factor: 1.475

Review 8.  Visual prognosis of optic glioma.

Authors:  Jeong-Min Hwang; Jung-Eun Cheon; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2008-01-04       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.